102 related articles for article (PubMed ID: 10534060)
1. Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantation.
Dickson TM; Kusnierz-Glaz CR; Blume KG; Negrin RS; Hu WW; Shizuru JA; Johnston LL; Wong RM; Stockerl-Goldstein KE
Biol Blood Marrow Transplant; 1999; 5(5):299-305. PubMed ID: 10534060
[TBL] [Abstract][Full Text] [Related]
2. Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation.
Navarro WH; Loberiza FR; Bajorunaite R; van Besien K; Vose JM; Lazarus HM; Rizzo JD
Biol Blood Marrow Transplant; 2006 May; 12(5):541-51. PubMed ID: 16635789
[TBL] [Abstract][Full Text] [Related]
3. The impact of actual body weight-based chemotherapy dosing and body size on adverse events and outcome in older patients with breast cancer: Results from Cancer and Leukemia Group B (CALGB) trial 49907 (Alliance A151436).
Morrison VA; McCall L; Muss HB; Jatoi A; Cohen HJ; Cirrincione CT; Ligibel JA; Lafky JM; Hurria A
J Geriatr Oncol; 2018 May; 9(3):228-234. PubMed ID: 29233548
[TBL] [Abstract][Full Text] [Related]
4. Impact of Dose-Adjusted Melphalan in Obese Patients Undergoing Autologous Stem Cell Transplantation.
Shultes KC; Arp C; Stockerl-Goldstein K; Trinkaus K; DeFrates S
Biol Blood Marrow Transplant; 2018 Apr; 24(4):687-693. PubMed ID: 29225163
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy dose adjustment for obese patients undergoing hematopoietic stem cell transplantation: a survey on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Shem-Tov N; Labopin M; Moukhtari L; Ciceri F; Esteve J; Giebel S; Gorin NC; Schmid C; Shimoni A; Nagler A; Mohty M
Oncologist; 2015 Jan; 20(1):50-5. PubMed ID: 25480827
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics and pharmacodynamics of busulfan when combined with melphalan as conditioning in adult autologous stem cell transplant recipients.
Willcox A; Wong E; Nath C; Janson B; Harrison SJ; Hoyt R; Bajel A; Shaw P; Ritchie D; Grigg A
Ann Hematol; 2018 Dec; 97(12):2509-2518. PubMed ID: 30051172
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Body Mass Index and Weight-Adjusted Fluid Dosing on Mortality in Sepsis.
Ward MA; Kuttab HI; Lykins V JD; Wroblewski K; Hughes MD; Keast EP; Kopec JA; Rourke EM; Purakal J
J Intensive Care Med; 2022 Jan; 37(1):83-91. PubMed ID: 33213268
[TBL] [Abstract][Full Text] [Related]
8. Ideal Body Weight Is Useful For Predicting Neutrophil Engraftment and Platelet Recovery for Overweight and Obese Recipients in Single-Unit Cord Blood Transplantation.
Okada Y; Nakasone H; Konuma T; Uchida N; Tanaka M; Sugio Y; Aotsuka N; Nishijima A; Katsuoka Y; Ara T; Ota S; Onizuka M; Sawa M; Kimura T; Fukuda T; Atsuta Y; Kanda J; Kimura F
Transplant Cell Ther; 2022 Aug; 28(8):504.e1-504.e7. PubMed ID: 35577325
[TBL] [Abstract][Full Text] [Related]
9. Relationship of body mass index and arm anthropometry to outcomes after pediatric allogeneic hematopoietic cell transplantation for hematologic malignancies.
Hoffmeister PA; Storer BE; Macris PC; Carpenter PA; Baker KS
Biol Blood Marrow Transplant; 2013 Jul; 19(7):1081-6. PubMed ID: 23623893
[TBL] [Abstract][Full Text] [Related]
10. Myelosuppression by chemotherapy in obese patients with gynecological cancers.
Kamimura K; Matsumoto Y; Zhou Q; Moriyama M; Saijo Y
Cancer Chemother Pharmacol; 2016 Sep; 78(3):633-41. PubMed ID: 27485538
[TBL] [Abstract][Full Text] [Related]
11. The use of adjusted ideal body weight for overweight patients undergoing HPC mobilisation for autologous transplantation.
Hicks C; Trickett A; Kwan YL; Ramanathan S
Ann Hematol; 2012 Nov; 91(11):1795-801. PubMed ID: 22836946
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: a British Society of Blood and Marrow Transplantation registry study.
Chantry AD; Snowden JA; Craddock C; Peggs K; Roddie C; Craig JI; Orchard K; Towlson KE; Pearce RM; Marks DI;
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1310-7. PubMed ID: 17162213
[TBL] [Abstract][Full Text] [Related]
13. Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies.
Kusnierz-Glaz CR; Schlegel PG; Wong RM; Schriber JR; Chao NJ; Amylon MD; Hu WW; Negrin RS; Lee Y; Blume KG; Long GD
J Clin Oncol; 1997 Jan; 15(1):18-25. PubMed ID: 8996120
[TBL] [Abstract][Full Text] [Related]
14. Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT.
Fuji S; Takano K; Mori T; Eto T; Taniguchi S; Ohashi K; Sakamaki H; Morishima Y; Kato K; Miyamura K; Suzuki R; Fukuda T
Bone Marrow Transplant; 2014 Dec; 49(12):1505-12. PubMed ID: 25111511
[TBL] [Abstract][Full Text] [Related]
15. Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation.
Singhal S; Gordon LI; Tallman MS; Winter JN; Evens AM; Frankfurt O; Williams SF; Grinblatt D; Kaminer L; Meagher R; Mehta J
Bone Marrow Transplant; 2006 Mar; 37(6):553-7. PubMed ID: 16444282
[TBL] [Abstract][Full Text] [Related]
16. Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation.
Aplenc R; Zhang MJ; Sung L; Zhu X; Ho VT; Cooke K; Dvorak C; Hale G; Isola LM; Lazarus HM; McCarthy PL; Olsson R; Pulsipher M; Pasquini MC; Bunin N;
Blood; 2014 May; 123(22):3504-11. PubMed ID: 24711663
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience.
Anderson JE; Litzow MR; Appelbaum FR; Schoch G; Fisher LD; Buckner CD; Petersen FB; Crawford SW; Press OW; Sanders JE
J Clin Oncol; 1993 Dec; 11(12):2342-50. PubMed ID: 8246023
[TBL] [Abstract][Full Text] [Related]
18. Baseline body mass index among children and adults undergoing allogeneic hematopoietic cell transplantation: clinical characteristics and outcomes.
Gleimer M; Li Y; Chang L; Paczesny S; Hanauer DA; Frame DG; Byersdorfer CA; Reddy PR; Braun TM; Choi SW
Bone Marrow Transplant; 2015 Mar; 50(3):402-10. PubMed ID: 25531283
[TBL] [Abstract][Full Text] [Related]
19. Outcomes in obese and overweight acute myeloid leukemia patients receiving chemotherapy dosed according to actual body weight.
Wenzell CM; Gallagher EM; Earl M; Yeh JY; Kusick KN; Advani AS; Kalaycio ME; Mukherjee S; Tiu RV; Maciejewski JP; Sekeres MA
Am J Hematol; 2013 Oct; 88(10):906-9. PubMed ID: 23828018
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults.
Kasamon YL; Bolaños-Meade J; Prince GT; Tsai HL; McCurdy SR; Kanakry JA; Rosner GL; Brodsky RA; Perica K; Smith BD; Gladstone DE; Swinnen LJ; Showel MM; Matsui WH; Huff CA; Borrello I; Pratz KW; McDevitt MA; Gojo I; Dezern AE; Shanbhag S; Levis MJ; Luznik L; Ambinder RF; Fuchs EJ; Jones RJ
J Clin Oncol; 2015 Oct; 33(28):3152-61. PubMed ID: 26261255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
